Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

HARE Activators

HARE Activators consist of a diverse array of chemical compounds that indirectly influence the functional activity of HARE through modulation of intricate cellular signaling pathways. Forskolin, for example, effectively raises intracellular cAMP, which in turn activates PKA, a kinase that can phosphorylate specific substrates instrumental in enhancing endocytic pathways where HARE functions. Similarly, agents like Genistein, by inhibiting competitive tyrosine kinase signaling, allow for an augmentation of HARE's role in receptor-mediated endocytosis. Phorbol esters such as PMA activate PKC, which phosphorylates regulatory proteins in endocytosis, potentially increasing HARE activity. Disruption of intracellular calcium dynamics also plays a role; compounds like A23187 and Thapsigargin elevate cytosolic calcium, which is pivotal for activating calcium-dependent signaling pathways, indirectly enhancing HARE's role in vesicle trafficking and receptor turnover.

Additionally, HARE's endocytic capabilities are potentially amplified by compounds modifying lipid signaling, such as Sphingosine-1-phosphate, which modulates receptor recycling, a key aspect of HARE's functionality. PI3K inhibitors, including LY294002 and Wortmannin, might shift signaling dynamics to favor endocytic pathways where HARE is more active. This theoretical enhancement is further supported by the inhibitory actions of IBMX on phosphodiesterases, which boost PKA and PKG levels, and U73122, which by inhibiting phospholipase C could affect vesicle formation and turnover. Staurosporine, despite its broad-spectrum kinase inhibition, may paradoxically promote the activation of HARE by preventing the action of kinases that negatively regulate endocytic pathways. In a similar vein, Epigallocatechin gallate (EGCG) serves to dampen competitive kinase signaling, thereby potentially creating a more favorable environment for HARE activity within its specialized endocytic domain. Collectively, these HARE Activators, through their nuanced and targeted effects on cellular signaling, provide the biochemical framework for the potential enhancement of HARE-mediated endocytic functions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin increases intracellular cAMP levels, which can activate protein kinase A (PKA). PKA then phosphorylates various proteins that can lead to the activation of pathways in which HARE is involved, potentially enhancing HARE’s endocytic activity.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

D-erythro-Sphingosine-1-phosphate acts on its receptors to modulate signaling pathways, including those that regulate endocytosis and recycling of receptors, which could enhance the recycling capability of HARE and its associated endocytic functions.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

IBMX is a non-specific inhibitor of phosphodiesterases, which increases cAMP and cGMP levels, thereby enhancing PKA and PKG activity. This can indirectly increase the endocytic activity of HARE through phosphorylation of proteins involved in clathrin-mediated endocytosis.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein inhibits tyrosine kinases, which may decrease competitive signaling pathways and allow for the enhanced activity of receptor-mediated endocytosis, a process in which HARE is directly involved.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate proteins that regulate endocytosis and vesicle formation, potentially enhancing the functional activity of HARE in these processes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that could, by inhibiting competitive pathways, enhance the pathway in which HARE is involved, potentially increasing its activity in receptor-mediated endocytosis.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is another PI3K inhibitor that similarly to LY294002, may enhance HARE’s endocytic functionality by shifting the balance of signaling pathways.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 is an ionophore that increases intracellular calcium levels, activating calcium-dependent signaling pathways that are crucial for vesicle trafficking, potentially enhancing HARE's role in these processes.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a potent protein kinase inhibitor, which might lead to the selective activation of pathways in which HARE is involved by inhibiting kinases that negatively regulate HARE-associated processes.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin disrupts calcium storage and enhances cytosolic calcium levels, which could activate calcium-dependent endocytic pathways, potentially enhancing the activity of HARE in these pathways.